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reoperation, and stroke following MV repair (n=168, 18/168: male, mean age of 47.7
years old) between 1/91 and 12/02.
Methods: Early and late mortality, stroke, and freedom from re-operation were
assessed. Potential predictors of mortality, stroke and re-operation were entered into a
Cox regression model. Actuarial survival, freedom from stroke and freedom from reoper-
ation were determined by a log-rank test.
Results: Kaplan-Meyer estimates for survival, freedom from stroke and freedom from re-
operation at 10 years after MV repair were 92.6 ± 3.9 %, 84.8 ± 4.9 %, and 93.8± 2.3 %
respectively. Cox regression risk (RR) and 95% CI for predictors of late mortality was pre-
op stroke within 14 days prior to surgery: RR 1.81(1.06-2.76). Cox regression risk (RR)
and 95% CI for predictors of late stroke was late AF: RR 18.3 (6.8-49.3). Risks for re-
operation included pre-op NYHA class IV: RR 4.9 (1.1-21.8) and extended endocarditis
over one third of each leaflet: RR 2.3 (0.5-11.9). No patients required reoperation for sus-
tained or recurrent infection.
Conclusion: These results indicated that MV repair for MV endocarditis provided excel-
lent survival, freedom reoperation and freedom from re-infection with long-term durability
of repaired valves. Only pre-op stroke within 2 weeks before surgery predicted late mor-
tality.
1162-137 Valve Surgery in Octogenarians: In-Hospital and Long-
Term Outcomes
Eduardo Bossone, Alessandro Frigiola, Giuseppe Di Benedetto, Silvia Cirri, Antonello 
Panza, Andrea Ballotta, Paolo Righini, Gianniignazio L. Carbone, Jianming Fang, 
Alessandro Distante, Kim A. Eagle, Rajendra H. Mehta, National Research Institute, 
Lecce, Italy, University of Michigan, Ann Arbor, MI
Background: The aging of global population and the higher incidence of ischemic,
degenerative and calcific valve disease with advancing age have resulted in more octo-
generians being referred for valve surgery. However, the pre-operative risk factors and
the hospital and long-term outcomes in this age group are less known.
Methods: We evaluated 307 consecutive patients age >80 years undergoing valve sur-
gery at 3 major Italian cardiac centers (age 83±2.4 yrs, females=60%). Majority of
patients had aortic valve surgery (AVS) either alone (n=134) or with CABG (n=94), aortic
surgery (n=3) or mitral valve surgery (MVS, n=26). The remaining patients underwent
MVS alone or with CABG or tricuspid valve repair.
Results: Most common hospital complications included atrial arrhythmias (50%), need
for inotropic support >48 hours (37%), renal insufficiency (28%), congestive heart failure
(23%), respiratory failure (22%), and stroke (6%). Death at 30-day occurred in 30
patients (9.7 %). Multivariate logistic regression identified: NYHA class IV (OR=5.2, 95%
CI=1.9-14.0; p=0.001); diabetes (OR=2.8, 95% CI=1.1-7.1; p=0.027); hypertension
(OR=3.7, 95% CI=1.2-11; p=0.025); renal insufficiency at presentation (OR=3.4, 95%
CI=1.2-9.4; p=0.022); rheumatic etiology (OR=3.8, 95% CI=1.1-12.9; p=0.030) and left
ventricular ejection fraction <45% (OR=6.2, 95% CI=1.1-35.3; p=0.041) as predictors of
hospital death. At follow-up (42±30 months, range=1-134 months), there were 45 more
deaths. Mortality was highest in patients undergoing MVS combined with other valve sur-
gery or CABG (21.6%). However, among long term survivors (n=232), the NYHA class
improved between pre- (3.0+0.7) to post-operative (1.7+0.6) periods (p<0.0001).
Conclusions: For selected symptomatic octogenarians with valve disease, surgery may
be an effective therapeutic option associated with good long-term survival and improve-
ment in functional class. The risk predictors of hospital death among these patients iden-
tified in our study may help physicians while counseling patients and their families to
make them understand their risk of valve surgery.
1162-138 Should Patients With Severe Aortic Stenosis and 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention Prior to Aortic Valve 
Replacement?
Pramod K. Kuchulakanti, Seung-Woon Rha, Natalie Gevorkian, Maureen C. Abbott, 
Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron 
Waksman, Washington Hospital Center, Washington, DC
Background: Symptomatic severe valvular aortic stenosis (defined as echocardio-
graphic valve area<0.75cm2, peak velocity>4m/sec or peak instantaneous gradient of
>75mmHg) frequently co-exists with coronary artery disease (CAD). The recommended
strategy is aortic valve replacement (AVR) with aorto coronary bypass surgery (CABG).
We undertook a study to examine the outcome of percutaneous coronary intervention
(PCI) alone in patients who could not undergo AVR.
Methods: A retrospective analysis of the medical records of patients with aortic valve
disease who underwent PCI at Washington Hospital Center was conducted. The patients
were divided into two groups: PCI without AVR (Gp 1, n=28) and PCI with AVR (Gp 2,
n=55). The procedural complications, in-hospital course and 1-year clinical outcomes
were compared.
Results: Clinical characteristics were comparable except that patients in Gp 1 were eld-
erly (78.8±8.8 vs.68.8±9.4 years, p <0.001) and had more renal insufficiency (28.6% vs.
10.9%, p=0.04). Gp 1 patients had less coronary bypass grafts compared to Gp 2 (35.7%
vs. 58.2%, p=0.05). Procedural characteristics and post procedure complications were
similar. Post procedural CPK-MB elevation was significantly higher in Gp 1(28.6% vs.9.8
%, p=0.03). At 6 months and 1 year follow-up, patients in Gp 1 had more non-Q-wave
myocardial infarctions and mortality due to out of hospital events.
Conclusions: Patients with CAD and severe AS should not undergo PCI alone prior to
AVR.
1162-139 Ablation of Atrial Fibrillation as a Concomitant Cardiac 
Surgical Procedure: Clinical Results
Mark J. Cunningham, Becky Lopez, Mark L. Barr, Vaughn A. Starnes, Keck School of 
Medicine University of Southern California, Los Angeles, CA
Background: Surgical radiofrequency ablation of atrial fibrillation (AF) has become an
accepted practice. This study reviewed outcome data to evaluate its relationship to free-
dom from AF.
Methods: Patients with AF underwent surgical ablation as a concomitant cardiac proce-
dure. Ablation lesions were created with unipolar and/or bipolar radiofrequency instru-
ments. Both epicardial and endocardial approaches were used on the arrested or beating
heart via sternotomy. Lesion sets included isolation of the pulmonary veins, excision or
exclusion of the left atrial appendage, and serial ablation lines consistent with the modi-
fied Cox-maze procedure.
Results: Over 2.5 years, 30 consecutive patients underwent surgical ablation of atrial
fibrillation at our institution. 23 patients had persistent AF and 7 had paroxysmal AF. The
patient population had a mean age of 62±12 years (range 36-78), was 50% male and
50% female, with a mean LA diameter of 51±7mm, and a mean ejection fraction of
53±9%. Actuarial freedom from AF was 77% at the most recent visit with a mean follow-
up of 10±8 months.
Conclusion: Surgical ablation of AF using the radiofrequency ablation technique is safe
and effective to eliminate atrial fibrillation in 77% of patients. Increased age and moder-
ately reduced EF are associated with inferior success rates.
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868-1 Increased Tricuspid Regurgitation in Patients With 
Pulmonary Hypertension When Left Ventricular 
Dysfunction Is Present: A New Mechanism of 
Malcoaptation
Mordehay Vaturi, Judy Hung, Robert A. Levine, Massachusetts General Hospital, 
Boston, MA
Background: Tricuspid regurgitation (TR) alters prognosis in heart failure with pulmo-
nary hypertension (PHTN). Clinically, we observed more frequent and severe TR when
PHTN was associated with LV dysfunction (LVDys). Database review of 2,326 patients
(pts) with PHTN>50 mmHg confirmed moderate to severe TR in 63% with LVDys vs 43%
without it (p<.001). We explored whether this reflects differences in TR mechanism with
altered LV and septal geometry. Methods: 2D echoes were reviewed in 39 pts with
severe PHTN (70-100), 14 with normal LV and 25 with LVDys (EF=72±4 vs 23±5%).
Results: Pts with LVDys had higher prevalence of moderate and severe TR (72% vs
36%, p=.02) despite smaller RV end-diastolic area (4-chamber: 20±6 vs 26±8 cm2,
p=.04) and lower RV systolic pressure (75±5 vs 89±11, p<.001). % RV area change,
annular diameter, and apical leaflet tenting area were not different. Eccentric TR jets
were common in LVDys (68 vs 7%, p=.001), with the anterior leaflet buckling superior to
a more apically restricted septal leaflet. This accompanied LV bulging into the RV, partic-
ularly in 13/14 with septal akinesis. These differences persisted after matching pts for RV
pressure (average 76). Conclusion: In comparable degrees of PHTN, TR is more severe
with LVDys, with frequently eccentric jets indicating malcoaptation. This is associated
Mortality and Non-Q-Wave MI in Patients who Underwent PCI with and without 
AVR
PCI without AVR
(Gp1, n=28)
PCI with AVR
(Gp 2, n=55)
P value
Death in hospital 3.6% 3.6% 0.98
6 months Non-Q-wave MI 35.0% 11.9% 0.03
Death out of hospital 28.6% 7.0% 0.020
1 year Non-Q-wave MI 46.7% 12.8% 0.007
Death out of hospital 45.0% 9.8% 0.002
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with septal bulging into the RV, with potential for asymmetric changes in leaflet tethering.
The potential implications are for TR repair, including relief by alleviating LV remodeling.
8:45 a.m.
868-2 Cardiovascular Risk Factors and Outcomes in Patients 
With Definite Endocarditis: The International 
Collaboration on Endocarditis – Prospective Cohort 
Study
Christopher H. Cabell, Stamatios Lerakis, Christine Selton-Suty, Andrew Wang, Vance G. 
Fowler, Jr., Gilbert Habib, Carlos Mestres, Juan Carlos Pare, Yvette Bernard, Arnold 
Bayer, Elias Abrutyn, Bruno Hoen, Jose M. Miro, G. Ralph Corey, Gail Peterson, The ICE 
Investigators, Duke Clinical Research Institute, Durham, NC
Background: A large international, prospective study of patients with IE has not been
done.
Aim of Study: To determine the clinical findings, complications, and outcomes in patients
with IE utilizing the International Collaboration on Endocarditis (ICE) Prospective Cohort
Study (ICE-PCS).
Methods: ICE-PCS began enrollment 1 January 2000. Through 15 November 2002,
1024 cases of definite IE were enrolled by 34 centers representing 15 countries. Each
center utilized a standard case report form.
Results: The median age of the cohort was 57.0 years (IQR 43.0-71.0) and 67.3% of the
patients were male. The most common co-morbidities included dialysis dependence
(10.0%), diabetes (16.6%), and IV drug use (10.8%). Preceding dental procedures were
less common (7.9%) than other invasive procedures (18.7%). Other risk factors for IE
included: previous IE (12.0%), congenital heart disease (13.1%), and underlying valvular
heart disease (36.0%). The most common organisms were Staphylococcus aureus
(32.4%), viridans group streptococci (13.1%), and Enterococcus faecalis (10.6%). Vege-
tations were documented by echocardiography in 868 patients (84.9%) Valve involve-
ment was as follows: aortic (40.6%), mitral (49.1%), tricuspid (15.1%), and pulmonic
(1.3%). Surgery during the acute episode was common (45.2%) with regurgitation
(67.0%) and heart failure (41.3%) the most frequent indications. Complications of IE
were frequent: embolic events (stroke 16.7%, other emboli 22.7%), heart failure (31.3%),
intracardiac abscess (16.2%), and death (19.4%). In the univariate analyses the stron-
gest predictors of death were: age, diabetes, hemodialysis, chronic indwelling intrave-
nous catheters, stroke, heart failure, and intracardiac abscess (p<0.001 for all). The
causative microorganisms with the highest mortality were as follows: coagulase negative
staphylococci (26.0%), Staphylococcus aureus (24.2%) and Enterococci (21.1%)
(p=0.002 for all).
Conclusion:. Even in the modern era of antimicrobial therapy and sophisticated surgical
techniques, patients with IE during the initial hospitalization remain at significant risk for
both serious complications and death.
9:00 a.m.
868-3 Comparison of Left Ventricular Sphericity and Papillary 
Muscle Tethering in the Mechanism of Ischemic Mitral 
Regurgitation in Patients With Inferior Myocardial 
Infarction
Takeshi Uemura, Yutaka Otsuji, Toshiro Kumanohoso, Kunitsugu Takasaki, Toshinori 
Yuasa, Kenichi Nakashiki, Bo Yu, Akira Kisanuki, Shinichi Minagoe, Robert A. Levine, 
Chuwa Tei, Kagoshima University, Kagoshima, Japan, Massachusetts General Hospital, 
Boston, MA
Background: Spherical left ventricle (LV) causes outward displacement of papillary mus-
cles (PMs) to induce leaflet tethering and ischemic mitral regurgitation (MR). However,
ischemic PM elongation can potentially attenuates effects of increased LV sphericity on
the ischemic MR, resulting in relatively weak relation between LV sphericity and severity
of MR.
Methods: In 50 consecutive patients with previous inferior MI, LV volume, LV ejection
fraction, mitral annular area, PM tethering distance, LV sphericity (LV short to long axis
dimension ratio in the apical 2-chamber view) and MR fraction were quantified by 2-
dimensional and Doppler echocardiography.
Results: 1) LV sphericity had significant but only fair correlation with % MR fraction (r2
=0.30, p=0.001) due to multiple patients with ischemic PM elongation and only modest
MR despite spherical LV. 2) In contrast, medial PM tethering distance had better correla-
tion with %MR fraction (r2 =0.69, p<0.001).
Conclusion: In the genesis of ischemic MR, LV sphericity, as opposed to tethering dis-
tance, is an indirect determinant, which can be affected by ischemic PM elongation.
9:15 a.m.
868-4 Natural History of Insignificant Mitral Regurgitation 
Following Aortic Valve Replacement for Degenerative 
Aortic Valve Disease
Shalini Sharma, Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical 
Center, Loma Linda, CA
Background: Mitral regurgitation (MR) is common in patients with denerative aortic valve
disease (AVD). Though the natural history following aortic valve replacement (AVR) of
significant accompanying MR is known, that of normal or nearly normal mitral valve func-
tion is uncertain.
Methods: One hundred and forty-seven patients who had AVR for degenerative AVD and
<2+ MR (on a 1-4 scale) on a preoperative echocardiogram were followed up for a mean
of 489 days with a second echocardiogram. Patient characteristics: age 63+13 years,
69% male, EF 50+16%, 65% had CABG. Reason for AVR was severe aortic stenosis in
54% and mixed aortic valve disease in the rest. Development of 3 or 4+ MR was related
to clinical, operative and echocardiographic variables.
Results: On the follow-up echocardiogram 3 or 4+ MR developed in 25 (17%) patients: 1
(2%) of the 44 patients with no preoperative MR, 8 of the 54 (15%) patients with 1+ pre-
operative MR and 16 (33%) of the 49 patients with 2+ preoperative MR. Risk factors for
the development of 3-4+ MR included female gender (p=0.05), greater age (68+11 vs
62+14 years, p=0.03), presence of left main disease (24 vs 10%, p=0.05) and greater
degree of preoperative MR (grade 1.6+0.6 vs 0.9+0.8, p<0.0001). Reduction in LV size
(p=0.08) following AVR was marginally protective.
Conclusion: 1) Significant (3-4+) MR may develop de novo over an intermediate term fol-
low-up in up to 33% of patients undergoing AVR. 2) Risk factors for its development
include female gender, older age, presence of left main disease and greater degrees of
preoperative MR. 3) Precise mechanism of its genesis and medical and surgical strate-
gies to its prevention need further investigations.
9:30 a.m.
868-5 Effects of Ramipril on Left Ventricular Size, Mitral 
Regurgitation Severity, Exercise Time, and Quality of 
Life in Asymptomatic Patients With Mitral Regurgitation
Kevin M. Harris, Charles F. Carey, Karen Bachnick, Betsy Wilson, Kristi Goertz, 
Minneapolis Heart Institute Foundation, Minneapolis, MN, Washington University School 
of Medicine, St. Louis, MO
There is no proven medical treatment for asymptomatic chronic mitral regurgitation (MR)
which progresses over time to a symptomatic state. Small studies have offered conflicting
results regarding the use of ace-inhibition. We assessed the effects of ramipril in asymp-
tomatic patients with chronic moderate to severe MR over a 6 month interval.
Methods: We assessed the effects of ramipril (5 mg bid) on 24 patients (mean age 49 +
15 years ) with moderate to severe MR. Echocardiographic assessment of MR severity
and left ventricular (LV) size were assessed at baseline and at 6 months. Exercise time,
neurohormonal levels and the Minnesota Living with Heart Failure score (MNLHF) were
also assessed.
Results: Systolic blood pressure was lower ( 133 ± 23 vs 123 ±15, mm HG , p=0.04) at a
mean f/u of 188 days. LV cavity size was similar as assessed by LV diastolic size (5.4 ±
0.5 vs 5.3 ± 0.6cm, P=NS) and LV end systolic volume index (21 ± 8 vs 21 ± 8 ml/m2,
p=NS). There was a trend towards reduction in effective regurgitant orifice (45 ± 4 vs 33
± 3 mm2, p=NS) but no change in MR as % of left atrial area (35 vs 36% , p=NS). There
was no change in exercise time (585 ± 219 seconds vs 583 ± 200 , p=NS) or MNLHF
scores (10 ±11 vs 10 ± 9, p=NS) . There was additionally no change in atrial natiuretic
factor (50 ± 51vs 56 ± 46, p=NS), or norepinephrine (247 ± 112 vs 258 ± 76, p=NS).
Conclusions: Treatment of patients with MR with ace inhibition over a 6 month interval
did not result in a significant reduction in LV cavity size or MR severity. We noted no sig-
nificant change in exercise time, neurohormone levels or quality of life score despite a
lower SBP at f/u. Further study will be needed to determine if there is a role for ace inhi-
bition in selected patients with mitral regurgitation.
